MCC MEDIA

LEGAL MARKETING SPECIALISTS / WEBSITE DESIGN AND DEVELOPMENT

Topics and Cases - Fosamax

Alendronic acid or alendronate sodium is sold as Fosamax in the United States. Fosamax is a bisphosphaonate drug used for osteoporosis and several other bone diseases. It is marketed alone as well as in combination with vitamin D (2,800 IU and 5600 IU, under the name Fosamax+D). It inhibits osteoclast-mediated bone-resorption. Like all bisphosphonates, it is chemically related to inorganic pyrophosphate, the endogenous regulator of bone turnover. Whereas pyrophosphate and the first bisphosphonate, etidronate, are capable of inhibiting both osteoclastic bone resorption as well as the mineralization of the bone newly formed by osteoblasts, Fosamax specifically inhibits bone resorption without any effect on mineralization at pharmacologically achievable doses.

Long term use of Fosamax has been shown to cause femoral fractures, dead jaw syndrome, gastrointestinal ulcerations and an increased risk of cancer. If you or a loved one has taken Fosamax, please read on for facts about the product and the litigation surrounding it.

Facts about Fosamax:

Litigation News: